Found 8 matching trials
Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis
PHASE1This study assessed the safety and pharmacokinetics (PK) of a single dose a...
Location
Mosaic Dermatology
Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
PHASE3This is a double-blind, parallel group, vehicle-controlled study to assess ...
Location
Arcutis Biotherapeutics Clinical Site 127
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II)
PHASE3This study will assess the safety and efficacy of ARQ-151 cream vs vehicle ...
Location
Arcutis Clinical Site 31
Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis
PHASE2The study will assess the safety, pharmacokinetics (PK), and efficacy of di...
Location
Arcutis Clinical Site 25
Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
PHASE3This study will assess the safety and efficacy of ARQ-151 cream vs placebo ...
Location
Arcutis Biotherapeutics Clinical Site 203
The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis
PHASE2This is a parallel group, double blind, vehicle-controlled study in which r...
Location
Arcutis Clinical Site 35
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (Integument-PED)
PHASE3This was a Phase 3, 4-week, double-blind study to assess the safety and eff...
Location
Arcutis Clinical Site 56
Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
PHASE3This is a parallel group, double blind, vehicle-controlled study to assess ...
Location
Arcutis Clinical Site 57